Continuous Venovenous Hemofiltration (CVVH) Product Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH) PRODUCT INDUSTRY

2.1 Summary about Continuous Venovenous Hemofiltration (CVVH) Product Industry

2.2 Continuous Venovenous Hemofiltration (CVVH) Product Market Trends

2.2.1 Continuous Venovenous Hemofiltration (CVVH) Product Production & Consumption Trends

2.2.2 Continuous Venovenous Hemofiltration (CVVH) Product Demand Structure Trends

2.3 Continuous Venovenous Hemofiltration (CVVH) Product Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Dialysate and Replacement Fluids

4.2.2 Disposables

4.2.3 Bloodline Sets

4.2.4 Hemofilters

4.2.5 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Clinic

4.3.2 Hospital

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Dialysate and Replacement Fluids

5.2.2 Disposables

5.2.3 Bloodline Sets

5.2.4 Hemofilters

5.2.5 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Clinic

5.3.2 Hospital

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Dialysate and Replacement Fluids

6.2.2 Disposables

6.2.3 Bloodline Sets

6.2.4 Hemofilters

6.2.5 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Clinic

6.3.2 Hospital

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Dialysate and Replacement Fluids

7.2.2 Disposables

7.2.3 Bloodline Sets

7.2.4 Hemofilters

7.2.5 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Clinic

7.3.2 Hospital

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Dialysate and Replacement Fluids

8.2.2 Disposables

8.2.3 Bloodline Sets

8.2.4 Hemofilters

8.2.5 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Clinic

8.3.2 Hospital

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Dialysate and Replacement Fluids

9.2.2 Disposables

9.2.3 Bloodline Sets

9.2.4 Hemofilters

9.2.5 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Clinic

9.3.2 Hospital

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Baxter International Inc. (U.S.)

10.1.2 Fresenius Medical Care AG & Co. KGaA (Germany)

10.1.3 Nikkiso Co., Ltd. (Japan)

10.1.4 B. Braun Melsungen AG (Germany)

10.1.5 Bellco S.r.l. (Italy)

10.1.6 NxStage Medical, Inc. (U.S.)

10.1.7 Asahi Kasei Corporation (Japan)

10.1.8 Infomed SA (Switzerland)

10.1.9 Medica S.p.A. (Italy)

10.1.10 Toray Medical Co., Ltd. (Japan)

10.2 Continuous Venovenous Hemofiltration (CVVH) Product Sales Date of Major Players (2017-2020e)

10.2.1 Baxter International Inc. (U.S.)

10.2.2 Fresenius Medical Care AG & Co. KGaA (Germany)

10.2.3 Nikkiso Co., Ltd. (Japan)

10.2.4 B. Braun Melsungen AG (Germany)

10.2.5 Bellco S.r.l. (Italy)

10.2.6 NxStage Medical, Inc. (U.S.)

10.2.7 Asahi Kasei Corporation (Japan)

10.2.8 Infomed SA (Switzerland)

10.2.9 Medica S.p.A. (Italy)

10.2.10 Toray Medical Co., Ltd. (Japan)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Continuous Venovenous Hemofiltration (CVVH) Product Product Type Overview

2.Table Continuous Venovenous Hemofiltration (CVVH) Product Product Type Market Share List

3.Table Continuous Venovenous Hemofiltration (CVVH) Product Product Type of Major Players

4.Table Brief Introduction of Baxter International Inc. (U.S.)

5.Table Brief Introduction of Fresenius Medical Care AG & Co. KGaA (Germany)

6.Table Brief Introduction of Nikkiso Co., Ltd. (Japan)

7.Table Brief Introduction of B. Braun Melsungen AG (Germany)

8.Table Brief Introduction of Bellco S.r.l. (Italy)

9.Table Brief Introduction of NxStage Medical, Inc. (U.S.)

10.Table Brief Introduction of Asahi Kasei Corporation (Japan)

11.Table Brief Introduction of Infomed SA (Switzerland)

12.Table Brief Introduction of Medica S.p.A. (Italy)

13.Table Brief Introduction of Toray Medical Co., Ltd. (Japan)

14.Table Products & Services of Baxter International Inc. (U.S.)

15.Table Products & Services of Fresenius Medical Care AG & Co. KGaA (Germany)

16.Table Products & Services of Nikkiso Co., Ltd. (Japan)

17.Table Products & Services of B. Braun Melsungen AG (Germany)

18.Table Products & Services of Bellco S.r.l. (Italy)

19.Table Products & Services of NxStage Medical, Inc. (U.S.)

20.Table Products & Services of Asahi Kasei Corporation (Japan)

21.Table Products & Services of Infomed SA (Switzerland)

22.Table Products & Services of Medica S.p.A. (Italy)

23.Table Products & Services of Toray Medical Co., Ltd. (Japan)

24.Table Market Distribution of Major Players

25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

27.Table Global Continuous Venovenous Hemofiltration (CVVH) Product Market Forecast (Million USD) by Region 2021f-2026f

28.Table Global Continuous Venovenous Hemofiltration (CVVH) Product Market Forecast (Million USD) Share by Region 2021f-2026f

29.Table Global Continuous Venovenous Hemofiltration (CVVH) Product Market Forecast (Million USD) by Demand 2021f-2026f

30.Table Global Continuous Venovenous Hemofiltration (CVVH) Product Market Forecast (Million USD) Share by Demand 2021f-2026f